Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
harmony biosciences
Overview
Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for rare neurological diseases, particularly sleep disorders like narcolepsy. As a key player in the orphan drug market, Harmony Biosciences' primary focus is on maximizing the commercial potential of WAKIX (pitolisant), its approved treatment for excessive daytime sleepiness in adults with narcolepsy. The company operates within the biopharmaceutical sector, concentrating on niche therapeutic areas with significant unmet medical needs and demonstrating a commitment to improving the lives of patients with debilitating neurological conditions through targeted therapies and strategic lifecycle management.
harmony biosciences's headcount breakdown by department
| Department | HeadCount |
|---|---|
Administrative | 7 |
Consulting | 0 |
Service | 2 |
Design | 0 |
Education | 1 |
Harmony Biosciences exhibits a workforce heavily skewed towards commercial operations, which is characteristic of a pharmaceutical company primarily focused on maximizing revenue from an approved product. The strong Sales department, representing the largest employee group, underscores a significant investment in market penetration and driving WAKIX adoption. A substantial Medical Affairs team is crucial for engaging with healthcare providers, disseminating clinical data, and building advocacy for the drug. The Operations team's size reflects the importance of efficient supply chain management and ensuring reliable product availability. Functional support departments such as Finance, Legal, and HR are appropriately sized to support the commercial business. While Marketing plays a vital role in brand awareness and promotional activities, the comparatively smaller Research team suggests a focus on post-market studies and lifecycle management activities rather than extensive early-stage drug discovery. The 'Other Department' category likely encompasses roles supporting commercial operations which do not fit directly into the listed departments. Overall, Harmony Biosciences' organizational structure reflects a sales-driven, commercially focused model centered around its existing product, indicating a strategic emphasis on efficient commercialization and market expansion.
harmony biosciences's employees by locations
Employee Count by Country
Total: 222 employees
Harmony Biosciences operates as a predominantly domestic company, with the vast majority of its workforce concentrated in the United States. This reflects the company's primary market focus on the U.S. pharmaceutical landscape, where WAKIX is approved and marketed. The limited presence in Australia and India suggests a minimal international footprint, likely attributable to supporting clinical trials, regulatory affairs activities, or early-stage market evaluation for potential future expansion. This geographic strategy aligns with a business model where the immediate priority is optimizing the revenue potential of WAKIX within the U.S. market. While international expansion may be considered in the future, the current allocation of resources reflects a focused approach on the company's core domestic market, strategically minimizing risk and optimizing resource allocation for its lead product.
Want to stay ahead of harmony biosciences's org changes?
Get alerts when hiring spikes or teams shift focus
Track changes vs. competitors
Spot warm GTM signals early